Creative Touch Permanent Makeup and Aesthetics

Magnesium is an essential mineral involved in approximately 300 enzymatic reactions including ATP activation, DNA repair, and cortisol regulation. An estimated 60% of adults in Western populations fail to reach adequate dietary intake, yet most routine blood tests are structurally incapable of detecting the depletion – only 0.3% of total body magnesium circulates in serum, and the body actively raids intracellular and bone stores to maintain that fraction within its narrow reference range. People starting Mounjaro often arrive with pre-existing subclinical depletion driven by obesity-related insulin resistance, then face further losses from gastrointestinal side effects and reduced food intake. The 2025 Mozaffarian multi-society advisory lists magnesium as a specific nutrient of concern during GLP-1 therapy and recommends supplementation.

Magnesium is the fourth most abundant mineral in the human body and a cofactor in roughly 300 enzymatic reactions spanning energy metabolism, protein synthesis, DNA repair, neuromuscular function, and inflammatory signalling. Its role in energy production is not incidental: every molecule of adenosine triphosphate must bind a magnesium ion (Mg-ATP) to become biologically active. Without adequate magnesium, ATP exists in the cell but cannot function – which means magnesium depletion impairs cellular energy production at its most fundamental step, independent of caloric intake or mitochondrial capacity. ^[6]

How Magnesium Is Distributed – and Why Testing Is Unreliable

Understanding why magnesium deficiency is so frequently missed requires understanding where the mineral actually lives in the body. Of total body magnesium stores, approximately 53% is held in bone, 27% in muscle, 19% in soft tissue and organs – and just 0.8% circulates in blood, with only 0.3% measurable in serum. ^[7]

This distribution creates a diagnostic problem that is unique among essential minerals. Because serum magnesium represents such a small fraction of total stores, and because the kidney is highly effective at conserving or excreting magnesium to maintain serum levels within a narrow homeostatic window, blood levels can appear entirely normal while intracellular and bone reserves are being progressively depleted. The body prioritises serum stability at the expense of the much larger tissue pool – which is precisely the opposite of what a diagnostic test needs to detect declining stores. ^[7]

The serum reference range in use (0.7–1.0 mmol/L) was established from a 1971–74 US study and has not been substantially updated since. A 2016 expert panel published in Advances in Nutrition – drawing on 183 peer-reviewed studies published between 1990 and 2008 – concluded directly: “The perception that ‘normal’ serum magnesium excludes deficiency is common among clinicians. This perception is probably enforced by the common laboratory practice of highlighting only abnormal results. A health warning is therefore warranted regarding potential misuse of ‘normal’ serum magnesium.” ^[1]

Red blood cell (RBC) magnesium, which measures intracellular erythrocyte content, is a meaningfully better proxy for tissue magnesium status and detects depletion considerably earlier than serum. However, it is not routinely ordered in UK primary care, the reference ranges for clinical interpretation are less standardised, and even RBC magnesium has limitations as a proxy for muscle or bone stores. The practical consequence for Mounjaro users is that a GP blood test returning a “normal” magnesium level should not be taken as reassurance that magnesium status is adequate – it may simply confirm that the homeostatic mechanism is still functioning.

Clinical Pearl Serum magnesium measures 0.3% of total body stores and is actively buffered to appear normal. A normal result does not exclude clinically significant depletion. In clients with obesity, diabetes, or high processed food intake, a symptom-based and risk-factor-based assessment is more informative than the blood result alone.

The Energy Mechanism: Mg-ATP

Magnesium’s role in energy metabolism operates through a mechanism that is direct rather than incidental. ATP – the cell’s primary energy currency – must complex with a magnesium ion to adopt the conformation recognised by the enzymes that hydrolyse it for energy. Uncomplexed ATP (ATP⁴⁻) cannot serve as a substrate for most ATPases, kinases, or synthetases. The biologically active form is Mg-ATP²⁻. ^[6]

This means that the oxidative phosphorylation process described in the Langer et al. (2026) proteomics data – the upregulation of SIRT5, COX5A, NDUFB8, and UQCRB in skeletal muscle following GLP-1 receptor activation – generates ATP that remains functionally inert if magnesium is unavailable to activate it. The cell can produce energy currency that it cannot spend. This is the cellular mechanism connecting magnesium depletion directly to fatigue, and it is distinct from the caloric supply problem: even well-nourished Mounjaro users with adequate protein intake will feel the energy consequences of inadequate magnesium, because the issue is at the activation step rather than the synthesis step. ^[7]

Beyond ATP activation, magnesium is required for the function of Na-K ATPase (the membrane pump maintaining cellular ion gradients), for HMG- CoA reductase in the cholesterol synthesis pathway – a route also suppressed by elevated cortisol – and for the glycolytic enzymes phosphoglucose isomerase and phosphofructokinase. Fatigue at low magnesium is therefore multisource: impaired ATP activation, disrupted membrane potential, and reduced glycolytic throughput are all contributing simultaneously.

Why People on Mounjaro Often Start From Depletion

The 60% of adults estimated to fail adequate dietary magnesium intake represents a general population baseline. ^[7] For people with obesity, the baseline is meaningfully worse – and the mechanism involves the same hormonal axis that Mounjaro is treating.

Insulin directly increases renal magnesium excretion. A controlled infusion study demonstrated that physiological concentrations of insulin produced a specific and dose-dependent increase in urinary magnesium output – a finding the authors described as a plausible explanation for the magnesium depletion observed in hyperinsulinaemic states including diabetes, hypertension, and obesity. ^[2] In insulin-resistant individuals, the compensatory hyperinsulinaemia required to maintain glucose control chronically elevates renal magnesium losses. Over months and years, this creates a progressive, silent depletion that standard serum testing will not detect until stores are severely compromised.

The relationship is bidirectional, which makes it genuinely self-reinforcing. Magnesium deficiency impairs insulin receptor signalling – specifically the tyrosine kinase activity of the receptor’s intracellular domain – worsening insulin resistance, which sustains the compensatory hyperinsulinaemia, which continues the renal wasting. ^[3] Multiple observational studies have confirmed that obese individuals have lower serum and intracellular magnesium than non-obese controls matched for age, with the magnitude of magnesium depletion correlating with HOMA-IR insulin resistance scores. ^[3]

Compounding this, the dietary patterns associated with obesity – high in processed and ultra-processed foods – are specifically low in magnesium. Processing techniques including grain bleaching can reduce magnesium content by up to 80%. ^[7] The highest dietary magnesium sources – dark leafy greens, nuts, seeds, wholegrains – tend to be consumed at low volumes in high-energy, processed-food-dominant diets.

The practical implication is that many people beginning tirzepatide are starting from a state of pre-existing subclinical magnesium depletion driven by hyperinsulinaemia and dietary pattern – a depletion that their most recent blood test did not detect and their prescriber does not know about.

What Changes on Mounjaro – and What Doesn’t, Initially

Tirzepatide’s dual GLP-1/ GIP agonism improves insulin sensitivity as treatment continues. As insulin resistance resolves and circulating insulin levels normalise, the renal magnesium wasting driven by hyperinsulinaemia should diminish – the trajectory here, as with ferritin and energy levels generally, is positive over time. ^[5]

But the early weeks run in the opposite direction. Before insulin sensitivity has meaningfully improved – typically the first four to eight weeks – gastrointestinal side effects add acute losses through vomiting and diarrhoea. Plain water replaces fluid volume but not electrolytes. Appetite suppression simultaneously reduces dietary magnesium intake. And hyperinsulinaemia-driven renal excretion continues until insulin levels have fallen in response to improving sensitivity.

The 2025 Mozaffarian multi-society advisory – a joint statement from four professional nutrition and obesity societies published simultaneously across multiple journals – explicitly identifies magnesium as a specific nutrient of concern during GLP-1 therapy and recommends supplementation as a routine consideration rather than a targeted response to confirmed deficiency. The advisory’s rationale reflects precisely this convergence of reduced intake, GI losses, and pre-existing depletion risk. ^[5]

Magnesium, Sleep, and Cortisol

Two additional mechanisms are worth understanding, because both interact with the fatigue picture in ways that are distinct from the ATP pathway.

Magnesium acts as a physiological antagonist at NMDA (N-methyl-D-aspartate) receptors in the central nervous system, reducing excitatory neuronal firing. It also enhances GABA-A receptor function, promoting inhibitory neurotransmission. Both effects contribute to the transition from wakefulness to sleep – magnesium’s blocking of NMDA receptors in the hypothalamic suprachiasmatic nucleus appears to facilitate circadian entrainment and sleep onset. ^[4] The clinical relevance here is not that magnesium supplementation produces dramatic sedative effects, but that chronic depletion may contribute to the difficulty initiating and sustaining sleep that some Mounjaro users report – adding a neurological dimension to the sleep disruption that GI symptoms alone do not fully explain.

The cortisol relationship is bidirectional. Cortisol elevates urinary magnesium excretion through mechanisms affecting renal tubular reabsorption. This means that the chronic low-grade psychological stress common in people navigating significant medical treatment, dietary restriction, and body change is itself a drain on magnesium stores. Magnesium depletion, in turn, increases sensitivity to the HPA axis stress response – a cycle that the cortisol entity describes in the context of barrier lipid suppression operates equally at the energy-metabolism level. ^[4]

Supplementation: Form, Timing, and What to Expect

Not all supplemental magnesium is equivalent in absorption or tolerability. Inorganic forms – magnesium oxide, carbonate, and hydroxide – have lower bioavailability and commonly cause gastrointestinal discomfort including loose stools, which is a particular concern during a period when GI side effects are already a significant feature. Organic chelate and amino acid complex forms – magnesium glycinate (bisglycinate), malate, and threonate – generally offer better absorption with fewer gastrointestinal effects. ^[7] For Mounjaro users, the choice of form is not trivial: the last thing someone managing nausea and diarrhoea needs is a supplement that worsens it.

Magnesium glycinate in particular has good tolerability evidence and supports the sleep pathway through the glycine component (glycine is independently associated with sleep quality improvement). Magnesium malate – bound to malic acid – may be preferable for muscle cramp and energy-related symptoms given malic acid’s role in the Krebs cycle.

Typical supplemental doses of 200–400 mg elemental magnesium daily are well within safe ranges. A 24-hour delay before effects on muscle cramps is typical; sleep effects, where they occur, are generally noticed within days. The energy effects of replenishing genuinely depleted magnesium stores take longer – several weeks – because the tissue reservoir depletion takes time to reverse even with consistent supplementation. Realistic expectations matter: supplementation will not produce an immediate energy uplift in the way that a strong coffee does. It removes a limitation on cellular function rather than providing a stimulus.